Adamiszak, A.; Derwich, K.; Bartkowska-Śniatkowska, A.; Pietrzkiewicz, K.; Niewiadomska-Wojnałowicz, I.; Czyrski, A.; Jusko, W.J.; Bienert, A.
Fluconazole Dosing for the Prevention of Candida spp. Infections in Hemato-Oncologic Pediatric Patients: Population Pharmacokinetic Modeling and Probability of Target Attainment Simulations. Pharmaceutics 2025, 17, 488.
https://doi.org/10.3390/pharmaceutics17040488
AMA Style
Adamiszak A, Derwich K, Bartkowska-Śniatkowska A, Pietrzkiewicz K, Niewiadomska-Wojnałowicz I, Czyrski A, Jusko WJ, Bienert A.
Fluconazole Dosing for the Prevention of Candida spp. Infections in Hemato-Oncologic Pediatric Patients: Population Pharmacokinetic Modeling and Probability of Target Attainment Simulations. Pharmaceutics. 2025; 17(4):488.
https://doi.org/10.3390/pharmaceutics17040488
Chicago/Turabian Style
Adamiszak, Arkadiusz, Katarzyna Derwich, Alicja Bartkowska-Śniatkowska, Krzysztof Pietrzkiewicz, Izabela Niewiadomska-Wojnałowicz, Andrzej Czyrski, William J. Jusko, and Agnieszka Bienert.
2025. "Fluconazole Dosing for the Prevention of Candida spp. Infections in Hemato-Oncologic Pediatric Patients: Population Pharmacokinetic Modeling and Probability of Target Attainment Simulations" Pharmaceutics 17, no. 4: 488.
https://doi.org/10.3390/pharmaceutics17040488
APA Style
Adamiszak, A., Derwich, K., Bartkowska-Śniatkowska, A., Pietrzkiewicz, K., Niewiadomska-Wojnałowicz, I., Czyrski, A., Jusko, W. J., & Bienert, A.
(2025). Fluconazole Dosing for the Prevention of Candida spp. Infections in Hemato-Oncologic Pediatric Patients: Population Pharmacokinetic Modeling and Probability of Target Attainment Simulations. Pharmaceutics, 17(4), 488.
https://doi.org/10.3390/pharmaceutics17040488
